Literature DB >> 32041197

Melittin-A Natural Peptide from Bee Venom Which Induces Apoptosis in Human Leukaemia Cells.

Michal Ceremuga1, Maksymilian Stela2, Edyta Janik3, Leslaw Gorniak3, Ewelina Synowiec4, Tomasz Sliwinski4, Przemyslaw Sitarek5, Joanna Saluk-Bijak6, Michal Bijak3.   

Abstract

Bee venom is a very complex mixture produced and secreted by the honeybee (Apis mellifera). Melittin is a major component of bee venom that accounts for about 52% of its dry mass. A vast number of studies have been dedicated to the effects of melittin's regulation of apoptosis and to the factors that induce apoptosis in various types of cancer such as breast, ovarian, prostate, lung. The latest evidence indicates its potential as a therapeutic agent in the treatment of leukaemia. The aim of our present study is to evaluate melittin's ability to induce apoptosis in leukaemia cell lines of different origin acute lymphoblastic leukaemia (CCRF-CEM) and chronic myelogenous leukaemia (K-562). We demonstrated that melittin strongly reduced cell viability in both leukaemia cell lines but not in physiological peripheral blood mononuclear cells (PMBCs). Subsequent estimated parameters (mitochondrial membrane potential, Annexin V binding and Caspases 3/7 activity) clearly demonstrated that melittin induced apoptosis in leukaemia cells. This is a very important step for research into the development of new potential anti-leukaemia as well as anticancer therapies. Further analyses on the molecular level have been also planned (analysis of proapoptotic genes expression and DNA damages) for our next research project, which will also focus on melittin.

Entities:  

Keywords:  apoptosis; bee venom; leukaemia; melittin

Year:  2020        PMID: 32041197     DOI: 10.3390/biom10020247

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  18 in total

1.  Development of D-melittin polymeric nanoparticles for anti-cancer treatment.

Authors:  Shixian Lv; Meilyn Sylvestre; Kefan Song; Suzie H Pun
Journal:  Biomaterials       Date:  2021-08-23       Impact factor: 15.304

Review 2.  Applications and evolution of melittin, the quintessential membrane active peptide.

Authors:  Shantanu Guha; Ryan P Ferrie; Jenisha Ghimire; Cristina R Ventura; Eric Wu; Leisheng Sun; Sarah Y Kim; Gregory R Wiedman; Kalina Hristova; Wimley C Wimley
Journal:  Biochem Pharmacol       Date:  2021-09-17       Impact factor: 6.100

Review 3.  Pharmacological effects and mechanisms of bee venom and its main components: Recent progress and perspective.

Authors:  Peiying Shi; Shihui Xie; Jiali Yang; Yi Zhang; Shuo Han; Songkun Su; Hong Yao
Journal:  Front Pharmacol       Date:  2022-09-27       Impact factor: 5.988

Review 4.  Perspectives and controversies regarding the use of natural products for the treatment of lung cancer.

Authors:  Tingting Wen; Lei Song; Shucheng Hua
Journal:  Cancer Med       Date:  2021-03-02       Impact factor: 4.452

5.  Effect of Bitis gabonica and Dendroaspis angusticeps snake venoms on apoptosis-related genes in human thymic epithelial cells.

Authors:  Francisc Boda; Krisztina Banfai; Kitti Garai; Bela Kovacs; Attila Almasi; Dalma Scheffer; Reka Lambertne Sinkler; Robert Csonka; Tamas Czompoly; Krisztian Kvell
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-12-14

6.  Cytotoxic and Pro-Apoptotic Effects of a Sub-Toxic Concentration of Fluvastatin on OVCAR3 Ovarian Cancer Cells After its Optimized Formulation to Melittin Nano-Conjugates.

Authors:  Shaimaa M Badr-Eldin; Nabil A Alhakamy; Usama A Fahmy; Osama A A Ahmed; Hani Z Asfour; Abdulhamid A Althagafi; Hibah M Aldawsari; Waleed Y Rizg; Wael A Mahdi; Adel F Alghaith; Sultan Alshehri; Filippo Caraci; Giuseppe Caruso
Journal:  Front Pharmacol       Date:  2021-02-03       Impact factor: 5.810

Review 7.  Bee Venom Components as Therapeutic Tools against Prostate Cancer.

Authors:  Jasmin Katrin Badawi
Journal:  Toxins (Basel)       Date:  2021-05-07       Impact factor: 4.546

8.  Development of an Icariin-Loaded Bilosome-Melittin Formulation with Improved Anticancer Activity against Cancerous Pancreatic Cells.

Authors:  Nabil A Alhakamy; Shaimaa M Badr-Eldin; Waleed S Alharbi; Mohamed A Alfaleh; Omar D Al-Hejaili; Hibah M Aldawsari; Basma G Eid; Rana Bakhaidar; Filippo Drago; Filippo Caraci; Giuseppe Caruso
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-15

Review 9.  Melittin-Based Nano-Delivery Systems for Cancer Therapy.

Authors:  Anqi Wang; Yuan Zheng; Wanxin Zhu; Liuxin Yang; Yang Yang; Jinliang Peng
Journal:  Biomolecules       Date:  2022-01-12

10.  In vitro and in vivo toxicity and antibacterial efficacy of melittin against clinical extensively drug-resistant bacteria.

Authors:  Parvin Askari; Mohammad Hasan Namaei; Kiarash Ghazvini; Mehran Hosseini
Journal:  BMC Pharmacol Toxicol       Date:  2021-07-14       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.